|Calculated MW||63225 Da|
|Purification||Antisera to LNK (NT) were raised by repeated immunisation of Goat with highly purified antigen.|
|Immunogen||Peptide sequence NGPALQPSSPC from LNK amino-terminus.|
|Shelf Life||18 months from date of despatch.|
|Other Names||SH2B adapter protein 3, Lymphocyte adapter protein, Lymphocyte-specific adapter protein Lnk, Signal transduction protein Lnk, SH2B3, LNK|
|Target/Specificity||Goat anti-Human LNK antibodyrecognizes human SH2B adapter protein 3, also known as Lymphocyte-specific adapter protein Lnk or Lymphocyte adapter protein. LNK is a 575 amino acid SH2B adapteer protein containing a single PH domain and a single SH2 domain. Goat anti-Human LNK antibody binds to an epitope within the N-terminal region of LNK, which regulates cytokine receptor-mediated and growth factor pathways, and plays an essential role in B cell lymphopoiesis.LNK mRNA is preferentially expressed in lymph node and spleen lymphocytes and the expression of LNK in vascular endothelial cells (ECs), increases in response to TNFα. LNK acts as a negative regulator of the pro-inflammatory molecules VCAM-1 and E-selectin induced by TNFα, modulation of P13-kinase and MAPK ERK1/2 activity. LNK is also involved in the negative regulation of Thrombopoietin-mediated cell proliferation and endomitosis in hematopoietic cell lines.|
|Preservative & Stabilisers||0.02% Sodium Azide; 0.5% Bovine Serum Albumin;|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human Lnk (N-Terminal) Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Fitau, J. et al. (2006) The adaptor molecule LNK negatively regulates TNFα-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and 2 pathways. J. Biol. Chem. 281: 20148-59 2. Devallière, J. et al. (2012) LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets a-parvin to control cell adhesion and migration.FASEB J. 26: 2592-606. 3. Gery, S. et al. (2007) Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders.Blood. 110: 3360-4. 4. Gery, S. et al.M (2009) Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.J Leukoc Biol. 85: 957-65. 5. Wan, M. et al. (2006) TNF-a Induces Lnk Expression Through PI3K-Dependent Signaling Pathway in Human Umbilical Vein Endothelial CellsJ Surg Res. 136: 53-7. 6. Fitau, J. et al. (2006) The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways.J Biol Chem. 281: 20148-59. 7. Wan, M. et al. (2007) Eicosapentaenoic acid inhibits TNF-alpha-induced Lnk expression in human umbilical vein endothelial cells: involvement of the PI3K/Akt pathway.J Nutr Biochem. 18: 17-22. 8. Chatelais, M. et al. (2011) Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection.Xenotransplantation. 18: 108-20. 9. Devallière, J. et al. (2012) LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets a-parvin to control cell adhesion and migration.FASEB J. 26: 2592-606. 10. Fitau, J. et al. (2005) The adaptor protein Lnk modulates endothelial cell activation.Nephrol Ther. 1: 228-33.1. Tong, W. and Lodish, H.F. (2004) Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.J. Exp. Med. 200: 569-580.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.